
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Germinal center‐derived lymphomas: The darkest side of humoral immunity
Coraline Mlynarczyk, Lorena Fontán, Ari Melnick
Immunological Reviews (2019) Vol. 288, Iss. 1, pp. 214-239
Open Access | Times Cited: 145
Coraline Mlynarczyk, Lorena Fontán, Ari Melnick
Immunological Reviews (2019) Vol. 288, Iss. 1, pp. 214-239
Open Access | Times Cited: 145
Showing 1-25 of 145 citing articles:
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright, Da Wei Huang, James D. Phelan, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 551-568.e14
Open Access | Times Cited: 856
George W. Wright, Da Wei Huang, James D. Phelan, et al.
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 551-568.e14
Open Access | Times Cited: 856
B cell memory: building two walls of protection against pathogens
Munir Akkaya, Kihyuck Kwak, Susan K. Pierce
Nature reviews. Immunology (2019) Vol. 20, Iss. 4, pp. 229-238
Open Access | Times Cited: 479
Munir Akkaya, Kihyuck Kwak, Susan K. Pierce
Nature reviews. Immunology (2019) Vol. 20, Iss. 4, pp. 229-238
Open Access | Times Cited: 479
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
Follicular lymphoma
Antonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 214
Antonino Carbone, Sandrine Roulland, Annunziata Gloghini, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 214
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis
Darko Barišić, Christopher R. Chin, Cem Meydan, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 583-604.e11
Closed Access | Times Cited: 21
Darko Barišić, Christopher R. Chin, Cem Meydan, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 583-604.e11
Closed Access | Times Cited: 21
T follicular helper cells in germinal center B cell selection and lymphomagenesis
Michelle A. Mintz, Jason G. Cyster
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 48-61
Open Access | Times Cited: 133
Michelle A. Mintz, Jason G. Cyster
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 48-61
Open Access | Times Cited: 133
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response
Wendy Béguelin, Matt Teater, Cem Meydan, et al.
Cancer Cell (2020) Vol. 37, Iss. 5, pp. 655-673.e11
Open Access | Times Cited: 120
Wendy Béguelin, Matt Teater, Cem Meydan, et al.
Cancer Cell (2020) Vol. 37, Iss. 5, pp. 655-673.e11
Open Access | Times Cited: 120
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Tanner J. Bakhshi, Philippe T. Georgel
Blood Cancer Journal (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 80
Tanner J. Bakhshi, Philippe T. Georgel
Blood Cancer Journal (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 80
Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells
Brice Laffleur, Junghyun Lim, Wanwei Zhang, et al.
Nature Genetics (2021) Vol. 53, Iss. 2, pp. 230-242
Open Access | Times Cited: 68
Brice Laffleur, Junghyun Lim, Wanwei Zhang, et al.
Nature Genetics (2021) Vol. 53, Iss. 2, pp. 230-242
Open Access | Times Cited: 68
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma
Manfei Pi, Huixian Kuang, Chunyan Yue, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100822-100822
Closed Access | Times Cited: 58
Manfei Pi, Huixian Kuang, Chunyan Yue, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100822-100822
Closed Access | Times Cited: 58
BTG1 mutation yields supercompetitive B cells primed for malignant transformation
Coraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Science (2023) Vol. 379, Iss. 6629
Open Access | Times Cited: 23
Coraline Mlynarczyk, Matt Teater, Juhee Pae, et al.
Science (2023) Vol. 379, Iss. 6629
Open Access | Times Cited: 23
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions
Qing Deng, Priya Lakra, Panhong Gou, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 605-622.e11
Open Access | Times Cited: 12
Qing Deng, Priya Lakra, Panhong Gou, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 605-622.e11
Open Access | Times Cited: 12
Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth
Yajing Xing, Chunbin Tan, Zhoujiang Liu, et al.
Journal of Natural Medicines (2025) Vol. 79, Iss. 2, pp. 399-411
Open Access | Times Cited: 1
Yajing Xing, Chunbin Tan, Zhoujiang Liu, et al.
Journal of Natural Medicines (2025) Vol. 79, Iss. 2, pp. 399-411
Open Access | Times Cited: 1
Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma
Daisuke Ennishi, Eric D. Hsi, Christian Steidl, et al.
Cancer Discovery (2020) Vol. 10, Iss. 9, pp. 1267-1281
Open Access | Times Cited: 64
Daisuke Ennishi, Eric D. Hsi, Christian Steidl, et al.
Cancer Discovery (2020) Vol. 10, Iss. 9, pp. 1267-1281
Open Access | Times Cited: 64
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma
Rebecca L. King, Eric D. Hsi, Wing C. Chan, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 193-205
Closed Access | Times Cited: 35
Rebecca L. King, Eric D. Hsi, Wing C. Chan, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 193-205
Closed Access | Times Cited: 35
Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma
Abdullah Alfaifi, Mohammed Y. Refai, Mohammed Alsaadi, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 861-861
Open Access | Times Cited: 17
Abdullah Alfaifi, Mohammed Y. Refai, Mohammed Alsaadi, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 861-861
Open Access | Times Cited: 17
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
Jie Li, Christopher R. Chin, Hsia‐Yuan Ying, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Jie Li, Christopher R. Chin, Hsia‐Yuan Ying, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
P. Romero, Laia Richart, Setareh Aflaki, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
P. Romero, Laia Richart, Setareh Aflaki, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences
Maria Stratigopoulou, Tijmen van Dam, Jeroen E. J. Guikema
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49
Maria Stratigopoulou, Tijmen van Dam, Jeroen E. J. Guikema
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 49
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation
Martín A. Rivas, Cem Meydan, Christopher R. Chin, et al.
Nature Immunology (2021) Vol. 22, Iss. 2, pp. 240-253
Open Access | Times Cited: 33
Martín A. Rivas, Cem Meydan, Christopher R. Chin, et al.
Nature Immunology (2021) Vol. 22, Iss. 2, pp. 240-253
Open Access | Times Cited: 33
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 28
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 28
NF-κB subunits direct kinetically distinct transcriptional cascades in antigen receptor-activated B cells
Mingming Zhao, Prashant Chauhan, Cheryl A. Sherman‐Baust, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1552-1564
Open Access | Times Cited: 15
Mingming Zhao, Prashant Chauhan, Cheryl A. Sherman‐Baust, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1552-1564
Open Access | Times Cited: 15
Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo
Dazhao Mi, Li Cheng, Yuzhan Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116789-116789
Closed Access | Times Cited: 5
Dazhao Mi, Li Cheng, Yuzhan Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116789-116789
Closed Access | Times Cited: 5
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
Zhenhua Chen, Chengwu Zeng, Lu Yang, et al.
Cell (2024)
Closed Access | Times Cited: 5
Zhenhua Chen, Chengwu Zeng, Lu Yang, et al.
Cell (2024)
Closed Access | Times Cited: 5